Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S. Read more about Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
Statement on BioNTech’s support for flood-hit areas in North Rhine-Westphalia and Rhineland-Palatinate Read more about Statement on BioNTech’s support for flood-hit areas in North Rhine-Westphalia and Rhineland-Palatinate
Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa Read more about Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa
BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD Read more about BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
U.S. FDA Grants Priority Review for the Biologics License Application for Pfizer-BioNTech COVID-19 Vaccine Read more about U.S. FDA Grants Priority Review for the Biologics License Application for Pfizer-BioNTech COVID-19 Vaccine
10 Million Doses of mRNA-based COVID-19 Vaccine to be supplied to Taiwan Region Read more about 10 Million Doses of mRNA-based COVID-19 Vaccine to be supplied to Taiwan Region
Pfizer and BioNTech Provide Update on Booster Program in Light of the Delta-Variant Read more about Pfizer and BioNTech Provide Update on Booster Program in Light of the Delta-Variant
BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma Read more about BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma
Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations Read more about Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations
Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents Read more about Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents
